CLX - The Clorox Company

NYSE - Nasdaq Real Time Price. Currency in USD
-0.52 (-0.33%)
As of 12:40PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close159.94
Bid159.37 x 1000
Ask159.42 x 1100
Day's Range158.95 - 160.14
52 Week Range127.34 - 167.70
Avg. Volume1,021,411
Market Cap20.305B
Beta (3Y Monthly)0.54
PE Ratio (TTM)26.09
Earnings DateN/A
Forward Dividend & Yield4.24 (2.65%)
Ex-Dividend Date2019-07-30
1y Target EstN/A
Trade prices are not sourced from all markets
  • Clorox Stock Looks Ready for a Clean Upside Breakout: Buy Strength
    TheStreet.com4 hours ago

    Clorox Stock Looks Ready for a Clean Upside Breakout: Buy Strength

    Commenting on Clorox Co. during the Lightning Round of Mad Money Tuesday night, Jim Cramer said: "The last quarter wasn't that good but the stock is still up. The technical indicators look like they can support an upside breakout in the near future. The daily On-Balance-Volume (OBV) line has been rising the past twelve months and it has just made a new high for the move up to foreshadow a potential breakout.

  • Barrons.com5 days ago

    Coca-Cola and 6 Other Consumer-Staples Stocks That Still Have Upside

    The staples sector has gained 19.9% this year, edging out most other sectors. The stocks appear to be rising almost entirely due to multiple expansion, rather than forecast earnings growth.

  • Markit8 days ago

    See what the IHS Markit Score report has to say about Clorox Co.

    Clorox Co NYSE:CLXView full report here! Summary * Perception of the company's creditworthiness is neutral * Bearish sentiment is moderate * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | NeutralShort interest is moderate for CLX with between 5 and 10% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NeutralETF activity is neutral. The net inflows of $9.02 billion over the last one-month into ETFs that hold CLX are not among the highest of the last year and have been slowing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Consumer Goods sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swap | NeutralThe current level displays a neutral indicator. CLX credit default swap spreads are within the middle of their range for the last three years.Please send all inquiries related to the report to and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Should We Worry About The Clorox Company's (NYSE:CLX) P/E Ratio?
    Simply Wall St.12 days ago

    Should We Worry About The Clorox Company's (NYSE:CLX) P/E Ratio?

    Today, we'll introduce the concept of the P/E ratio for those who are learning about investing. We'll apply a basic...

  • Clorox (CLX) Stock Loses Sheen: What's Hindering its Growth?
    Zacks12 days ago

    Clorox (CLX) Stock Loses Sheen: What's Hindering its Growth?

    Clorox (CLX) expects gross margin to be flat in fiscal 2019 as gains from higher prices and cost-savings efforts are likely to be offset by higher costs and adverse currency rates.

  • Can Personal Care Players Keep Producing Double-Digit Returns?
    Market Realist14 days ago

    Can Personal Care Players Keep Producing Double-Digit Returns?

    Shares of most US household and personal care manufacturers generated double-digit returns in the first half. What does the future hold?

  • TheStreet.com18 days ago

    These 3 Dividend Aristocrats Have Consumable Products as Part of Their Offerings

    When we talk Dividend Aristocrats and Dividend Kings, it should come as little surprise the Kings and their more than 50 years of increasing dividends earns the same as a lot in the Dividend Aristocrats, given they easily satisfy the criteria that is increasing their dividends for at least 25 years. This led me to suggest investors through the Kings for companies that have inelastic and defensible business models. Now let's do the same for the Dividend Aristocrats.

  • Procter & Gamble Moves Up the Charts: Will Growth Continue?
    Zacks28 days ago

    Procter & Gamble Moves Up the Charts: Will Growth Continue?

    Procter & Gamble (PG) emphasizes on improving its product portfolio through strategic initiatives. Also, the company is on track with its cost-saving plans.

  • Moody'slast month

    Clorox Company (The) -- Moody's announces completion of a periodic review of ratings of Clorox Company (The)

    Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Clorox Company (The) and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers. This publication does not announce a credit rating action and is not an indication of whether or not a credit rating action is likely in the near future.

  • Can 2020 Strategy Aid Clorox Despite Soft View & High Costs?
    Zackslast month

    Can 2020 Strategy Aid Clorox Despite Soft View & High Costs?

    Clorox (CLX) focuses on 2020 Strategy and digital efforts, as it faces the brunt of muted FY19 view.

  • UL or CLX: Which Is the Better Value Stock Right Now?
    Zackslast month

    UL or CLX: Which Is the Better Value Stock Right Now?

    UL vs. CLX: Which Stock Is the Better Value Option?

  • How Much is The Clorox Company's (NYSE:CLX) CEO Getting Paid?
    Simply Wall St.last month

    How Much is The Clorox Company's (NYSE:CLX) CEO Getting Paid?

    In 2014 Benno Dorer was appointed CEO of The Clorox Company (NYSE:CLX). This analysis aims first to contrast CEO...

  • American City Business Journalslast month

    These were last year's Most Admired CEOs. Who will this year's be?

    Every year since 2007, the San Francisco Business Times has picked a selection of successful, influential, seasoned business leaders to be recognized as the Bay Area's Most Admired CEOs. The leaders chosen for this honor are selected after months of research and discussion between editors and reporters. Another critical component, however, is the flood of nominations from readers and businesses.

  • Here’s What Hedge Funds Think About The Clorox Company (CLX)
    Insider Monkeylast month

    Here’s What Hedge Funds Think About The Clorox Company (CLX)

    The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We have processed the filings of the more than 700 world-class investment firms that we track and now have access to the collective wisdom contained in […]

  • Clorox (CLX) Up 0.6% Since Last Earnings Report: Can It Continue?
    Zacks2 months ago

    Clorox (CLX) Up 0.6% Since Last Earnings Report: Can It Continue?

    Clorox (CLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Could the Tide Soon Turn for Procter & Gamble Stock?
    InvestorPlace2 months ago

    Could the Tide Soon Turn for Procter & Gamble Stock?

    As the markets get ready to finish a volatile month, I'd like to discuss the outlook of Procter & Gamble (NYSE:PG), the consumer-goods titan, whose shareholders have had a great year. Over the past 12 months, PG stock is up over 40%.Source: Mike Mozart via Flickr (Modified)Although I would not bet against Procter & Gamble stock in the long-term, I do not find PG stock a compelling buy at its current prices. I expect PG to undergo volatility and possibly weakness in June. Despite the many catalysts that make the shares an important part of a diversified portfolio, the company also faces several short-term risks. Here are the most important things that investors should know about Procter & Gamble stock. * 7 Stocks to Sell Amid an Escalating Trade War Procter & Gamble Has Strong BrandsMany consumer-staples companies have famous brands and robust fundamentals. I'view PG as one of the best consumer-staple names. Founded in 1837, the company is one of the largest manufacturers, distributors, and advertisers of consumer goods globally.InvestorPlace - Stock Market News, Stock Advice & Trading TipsThe company has five main segments: * Beauty, * Grooming, * Health Care, * Fabric & Home Care, * Baby, Feminine & Family Care.With its extensive product portfolio, it covers all the basic needs of consumers. On a given day, the average U.S. (and global) household is likely to use many of its brands, including Tide, Bounty, Downy, Pampers, Always, Charmin, Swiffer, Head & Shoulders, Crest, and Gilette.The strength of Procter & Gamble's brands is helping it achieve broad geographic reach and the benefits of large size in this competitive industry. PG Stock Benefits From Robust EarningsPG's fiscal third-quarter results, announced on Apr. 23 ,showed that its sales growth sped up, as its organic sales increased 5%. Chief Financial Officer Jon Moeller highlighted the quarter as the "third quarter in a row of very strong volume, sales, consumption and market share growth being driven by a strategy of superiority."Global annual revenue is over $66 billion and almost two dozen of its brands have annual sales of over $1 billion. Because these products have high margins, PG's return on capital employed (ROCE), a profitability ratio measuring how efficiently a company can generate profits, has been about 16%, which is viewed as healthy.The company has achieved those numbers through both organic growth and acquisitions. For example, the power of its brands enables Procter & Gamble to raise its prices without sacrificing a great deal of sales volume.Furthermore, over the past three years, Procter & Gamble has completed seven acquisitions. For example, in Dec. 2018, it finalized a $4.2 billion deal to purchase Germany-based Merck KGaA's Consumer Health business. PG said that the deal would help it expand its portfolio of consumer-healthcare products. The acquisition has increased PG's exposure to Asian and Latin American markets.Finally, Procter & Gamble's AA credit rating is possibly one of the best testaments of the company's fundamental strength. Procter & Gamble Stock Creates Shareholder ValueAnalysts have highlighted Procter & Gamble's improved margins, helped by cost-cutting across the company. Over the past few years, management has reshaped the company's portfolio to better serve changing consumer trends and spending habits.Dividends should play an important part in long-term investments. As a dividend aristocrat, Procter & Gamble stock is a favorite among income investors.PG's dividend yield is almost 2.9%. Its robust free cash flow will probably enable it to further increase its dividends in coming years. The company has raised its dividend every year since 1957. Over the past decade, PG's dividend has jumped over 60%. PG Stock May Not Be Immune to the U.S.-China Trade WarsAlthough it may not be one of the first stocks most investors think of when assessing the potential impact of the U.S.-China trade wars, Procter & Gamble stock is likely to be adversely affected by increased tariffs. In 2018, PG's management reported that tariff increases would raise the cost of making many of its products.PG relies on China for many parts and materials, such as pipes, tanks, and containers, that are used to manufacture and package its brands.As tariffs rise, PG would either have to increase its prices or absorb the costs. Increasing prices could hurt its sales, while absorbing higher costs would undermine its profitability. Either way, there would likely be downward pressure on PG stock.In April, even before trade-war tensions began intensifying, PG CEO David Taylor stressed that the company faced "a challenging competitive and macroeconomic environment." The rhetoric on tariffs won't ease the headwinds that Taylor described or the pressure they put on PG stock price. Is the Valuation of PG Stock Becoming Stretched?Wall Street has been voicing concerns about the rich valuation of PG stock. InvestorPlace columnist Luke Lango recently analyzed why investors may want to pay close attention to various metrics which indicate that the valuation of Procter & Gamble stock has become stretched.Furthermore rising commodity costs have been impacting the entire consumer-staples sector in the past few months. For example, prices for inputs like plastic, paper, and oil have been rising. Indeed in Oct. 2018, PG blamed rising costs for price increases it levied on many of its brands.Therefore, the owners of PG stock may want to assess the company's sales volumes when it reports its earnings in late July and October, in order to see if they are being adversely affected by the price hikes.If PG's volumes stay flat or fall, then more analysts may begin to find the current valuation levels of PG stock rather high, resulting in downgrades of PG stock. In 2018, a number of analysts downgraded Procter & Gamble stock due to rising commodity costs and price pressures that affected every segment of the company. Should Investors Buy PG Stock in June?At PG's current levels, I would not buy PG stock. Procter & Gamble stock has many long-term growth catalysts. However, PG is facing shorter-term risks which are likely to push down PG stock price and deflate its valuation.Furthermore, as a result of the recent impressive rise of PG stock over the past year, its short-term technical indicators have become somewhat overextended. Investors who pay attention to short-term oscillators should note that Procter & Gamble stock has become "overbought."So, in the next few weeks, PG stock may be negatively impacted by profit-taking. Investors may want to wait for a better time to buy PG stock, such as when the share price is around $90.Finally, investors who are thinking of buying PG may also want to pay attention to upcoming earnings releases by PG's peers, including Colgate-Palmolive (NYSE:CL), Kimberly Clark (NYSE:KMB), and Clorox (NYSE:CLX). Any weakness in their reports will likely put downward pressure on Procter & Gamble stock.As of this writing, Tezcan Gecgil did not hold a position in any of the aforementioned securities. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 7 Stocks to Sell Amid an Escalating Trade War * 5 REITs to Buy While They're Dirt Cheap * The Only 3 Marijuana Stocks You Need to Own Compare Brokers The post Could the Tide Soon Turn for Procter & Gamble Stock? appeared first on InvestorPlace.

  • Clorox joins brands in Loop reusable packaging program
    American City Business Journals2 months ago

    Clorox joins brands in Loop reusable packaging program

    The Clorox Company (NYSE: CLX) has added two of its popular products to the list of items available through the TerraCycle Loop circular sustainable shopping pilot program. First announced at the World Economic Forum in January, Loop enables consumers to purchase commonly-used products in customized, durable packaging that is delivered in a reusable shipping tote. The initiative aims to establish a new model that supports responsible consumption and ends society’s dependence on disposability.

  • 4 Consumer Staples Stocks for Both Income and Growth
    InvestorPlace2 months ago

    4 Consumer Staples Stocks for Both Income and Growth

    In a world where investors focus on the tech stocks of the future, the equities representing the products we use every day often get ignored. When many investors hear "consumer staples stocks," they tend to think of names such as Procter & Gamble (NYSE:PG) or Clorox (NYSE:CLX). While those firms may make the products necessary for people's lives, they might also struggle to attract investor interest.However, investors should take a closer look at consumer staples stocks. Consumer staples is a diverse category, and some subsectors generate investor excitement. It can include consumer electronics. Additionally, the emerging marijuana and hemp sectors have also reinvigorated interest in consumer stocks. * 7 Utility Stocks to Trust for Retirement Moreover, due to depressed price-to-earnings (P/E) ratios for many consumer staples stocks, some offer not only deep value, but also increased cash payouts. These four consumer-oriented equities provide a unique opportunity for significant cash payouts and stock-price growth:InvestorPlace - Stock Market News, Stock Advice & Trading Tips Apple (AAPL)Source: Apple Consumers often forget that some consumer staples stocks come with a tech focus. Such is the case with Apple (NASDAQ:AAPL). The company has long depended on the iPhone for the majority of its revenue. However, amid competition, consumers have shown less willingness to pay Apple's premium prices. Moreover, traders also worry about how the U.S.-China trade war will affect the company. As a result, AAPL stock remains in a bear market.The good news for AAPL longs is that arguably no other company is better positioned to reinvent itself than Apple. In recent months, the company has ventured into streaming media, credit cards, information, and other businesses in an attempt to return to double-digit growth. Even after investing in some of these areas, their cash hoard stood at $225.4 billion at the end of the first quarter.Moreover, their trailing P/E ratio stands at about 15.4. While profits will likely stagnate this year, analysts forecast that Apple will return to double-digit profit growth in 2020. Furthermore, holders of AAPL stock now earn an annual dividend of $3.08 per share. Though this brings the yield to only about 1.6%, investors should note that payouts have increased every year since they began in 2012.Apple stock may struggle in the near term as the company explores new revenue streams and deals with a trade war. However, once the company profits from new businesses and the U.S. and China agree on trade, AAPL stock should again resume its move higher. Greif (GEF)Source: Apple Greif (NYSE:GEF) may not serve as one of the better-known consumer staples stocks. However, its packaging plays a vital role in the industrial sector. Moreover, the company's financial metrics may make some investors want to secure some GEF stock in their portfolio.Since the beginning of 2018, concerns about a slowing economy weighed on GEF stock. Investor worries worsened with the purchase of Caraustar industries earlier year. As a result, GEF trades at a discount of more than 40% from its 52-week high.The forecasted earnings growth of only 4.2% this year may explain some of the stock's decline. Still, profits have typically increased at double-digit rates in the past. Wall Street predicts that that growth rate will return next year with a 12% increase forecasted.Moreover, this also leaves its trailing P/E ratio at just 9.7 times earnings. This compares well to other consumer staples stocks as many trade at a multiple above 20. * 5 Large-Cap Stocks Getting Crushed in the Trade War Investors should also pay attention to the dividend. The annual payout of $1.76 per share takes the yield to around 4.75%. While that dividend does not increase every year, it has gradually moved higher over time. Between this payout and the low multiple, GEF stock holds tremendous potential as both a growth and an income play. United Breweries (CCU)Source: Shutterstock United Breweries (NYSE:CCU), known in its native Chile as Compañia Cervecerias Unidas S.A., is the number one producer of beer in Chile. United Breweries also derives a significant percentage of its revenue from Argentina, Uruguay, Paraguay, and Bolivia. Despite the beer-oriented name, the company also sells wine, spirits, and non-alcoholic drinks.Chile has gradually become one of Latin America's wealthiest countries. CCU stock has grown with the country. Despite this growth, CCU stock trades at a trailing P/E ratio of 10.4.Volatility may partially explain the low multiple in CCU stock. Analysts expect profits to increase by 76.9% this year. However, in 2020, they forecast an earnings decline of 26.2%. Still, they predict that growth to average 11.37% per year over the next five years. This represents a turnaround from previous years as profits had shrunk more often than not.That positive growth should also reduce the volatility of its dividend. The company will pay out $1.32 per share in dividends this year. That translates to a yield of 5.0% at current prices. Despite the yield and the improving profit picture, investors need to prepare for some fluctuation in the payout. The company paid only 36 cents per share in 2018, down from 56 cents per share in 2017.CCU stock will require stockholders to exercise patience with the ups and downs. However, for those that can handle the volatility, CCU should remain one of the consumer staples stocks that should have investors raising a glass. Nu Skin Enterprises (NUS)Nu Skin Enterprises (NYSE:NUS) utilizes multilevel marketing and social media to sell its dietary and skin-care products. It began operations in 1984 and sells its products under the Nu Skin and Pharmanex brands. Though it didn't sell outside of the U.S. until 1990, non-U.S. sales now account for about 88% of revenues.Consequently, worries about currency risk and trade in the second quarter have weighed on NUS stock, and it has struggled in recent days. The Provo, Utah-based firm spiked higher by 19% after beating on earnings and revenue in its 1Q 2019 report. However, in subsequent trading sessions, it has given most of that gain back as trade-related uncertainty returns. NUS stock trades at more than 40% below its 52-week high.However, that creates an opportunity among consumer staples stocks. Despite these worries, earnings forecasts for both this year and next have moved higher over the last 30 days. More importantly, these revisions point to double-digit earnings increases for both 2019 and 2020. This has helped to take its forward P/E ratio to around 11.7. * 5 Retail Stocks Getting Slaughtered This Earnings Season Also, thanks to the decline in the stock, the $1.48 dividend yields almost 2.9%. Since this payout has increased every year for the past 18 years, investors can probably expect the annual payout hikes to continue. Both the high, increasing payout and the low P/E ratio position NUS stock for both growth and income once trade war-related tensions ease.As of this writing, Will Healy did not hold a position in any of the aforementioned stocks. You can follow Will on Twitter at @HealyWriting. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 6 Marijuana Stocks With Critical Levels to Watch * 7 Utility Stocks to Trust for Retirement * 5 Large-Cap Stocks Getting Crushed in the Trade War Compare Brokers The post 4 Consumer Staples Stocks for Both Income and Growth appeared first on InvestorPlace.

  • UL vs. CLX: Which Stock Should Value Investors Buy Now?
    Zacks2 months ago

    UL vs. CLX: Which Stock Should Value Investors Buy Now?

    UL vs. CLX: Which Stock Is the Better Value Option?

  • Clorox (CLX) Boosts Shareholder Value With 10% Dividend Hike
    Zacks2 months ago

    Clorox (CLX) Boosts Shareholder Value With 10% Dividend Hike

    Clorox (CLX) enhances shareholder returns by a 10% hike in its quarterly dividend.

  • Clorox Stock: What Wall Street Recommends
    Market Realist2 months ago

    Clorox Stock: What Wall Street Recommends

    Why Clorox Stock Is Underperforming Peers(Continued from Prior Part)Analysts maintain a “hold” ratingMost analysts prefer to maintain a neutral stance on Clorox (CLX) stock. Clorox’s price restructuring initiatives and innovation are expected